ATE228143T1 - 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene - Google Patents

14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Info

Publication number
ATE228143T1
ATE228143T1 AT00909281T AT00909281T ATE228143T1 AT E228143 T1 ATE228143 T1 AT E228143T1 AT 00909281 T AT00909281 T AT 00909281T AT 00909281 T AT00909281 T AT 00909281T AT E228143 T1 ATE228143 T1 AT E228143T1
Authority
AT
Austria
Prior art keywords
hydroxymethylandrostane
androgens
beta
alpha
derivatives
Prior art date
Application number
AT00909281T
Other languages
German (de)
English (en)
Inventor
Hubert Jan Jozef Loozen
Dirk Leysen
Der Louw Jaap Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE228143T1 publication Critical patent/ATE228143T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00909281T 1999-03-08 2000-03-02 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene ATE228143T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99200665 1999-03-08
PCT/EP2000/001755 WO2000053619A1 (en) 1999-03-08 2000-03-02 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens

Publications (1)

Publication Number Publication Date
ATE228143T1 true ATE228143T1 (de) 2002-12-15

Family

ID=8239953

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00909281T ATE228143T1 (de) 1999-03-08 2000-03-02 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene

Country Status (11)

Country Link
US (1) US6881728B1 (enExample)
EP (1) EP1163259B1 (enExample)
JP (1) JP4749550B2 (enExample)
AR (1) AR022852A1 (enExample)
AT (1) ATE228143T1 (enExample)
AU (1) AU3162200A (enExample)
CA (1) CA2359218A1 (enExample)
CO (1) CO5150195A1 (enExample)
DE (1) DE60000826T2 (enExample)
PE (1) PE20001489A1 (enExample)
WO (1) WO2000053619A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL202999B1 (pl) 1999-12-02 2009-08-31 Organon Nv Androgeny zawierające pierścień cyklopropanowy w pozycjach 14, 15 i zastosowanie takich androgenów
ES2305131T3 (es) * 2000-12-11 2008-11-01 N.V. Organon Metileno esteroides como nuevos androgenos.
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002746A (en) * 1959-09-25 1977-01-11 Herchel Smith Synthesis of gon-4-enes
US3086027A (en) 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
US5264427A (en) * 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception

Also Published As

Publication number Publication date
AR022852A1 (es) 2002-09-04
US6881728B1 (en) 2005-04-19
DE60000826T2 (de) 2003-04-10
CO5150195A1 (es) 2002-04-29
PE20001489A1 (es) 2000-12-29
DE60000826D1 (de) 2003-01-02
CA2359218A1 (en) 2000-09-14
EP1163259A1 (en) 2001-12-19
JP4749550B2 (ja) 2011-08-17
EP1163259B1 (en) 2002-11-20
JP2002539135A (ja) 2002-11-19
AU3162200A (en) 2000-09-28
WO2000053619A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
ATE315036T1 (de) 2,4-diaminopyrimidinderivate als immunosuppressiva
MA26794A1 (fr) Derives de 5-phenyl-pyrimidine.
ITRM20000530A0 (it) Complesso di essiccazione.
BR0013417B1 (pt) composiÇço aquosa.
ATE317396T1 (de) 14,15-beta-methylen substituierte androgene
MA26793A1 (fr) Derives de 4-phenyl-pyrimidine.
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
ITBO990359A0 (it) Elettromandrino .
DE60003072D1 (de) Thiazolidindion-derivate als antidiabetika
ATE228143T1 (de) 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
IT1319526B1 (it) Macchina i.s.
IT1319528B1 (it) Macchina i.s.
NL1011488A1 (nl) Hoofdtelefoon-microfoon-combinatie.
FR2790466B1 (fr) Machine i.s.
ES1041748Y (es) Pantalon perfeccionado.
DE60017150D1 (de) 1,4,5,6 -tetrahydropyrimidine-derivative als vitronectin-hemmer
ES1044367Y (es) Piñata mejorada.
ITMI990856A1 (it) Composizione funghicida.
ES1044013Y (es) Nueva cantonera mejorada.
IT1311656B1 (it) Struttura di inserto, particolarmente per applicazione di cerniere asupporti.
ES1042809Y (es) Esponja-estropajo mejorado.
IT1313922B1 (it) Elettromandrino perfezionato.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties